These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8364335)

  • 21. HIV screening and blood transfusion.
    Neequaye AR
    West Afr J Med; 1993; 12(2):76. PubMed ID: 8398934
    [No Abstract]   [Full Text] [Related]  

  • 22. Retroviruses and blood transfusion.
    Contreras M; Barbara JA
    Baillieres Clin Haematol; 1990 Jan; 3(1):65-77. PubMed ID: 1969755
    [No Abstract]   [Full Text] [Related]  

  • 23. [Risk of transmission of HIV by blood products].
    Gürtler L
    Infusionsther Transfusionsmed; 1994 Oct; 21(5):295-6. PubMed ID: 7803990
    [No Abstract]   [Full Text] [Related]  

  • 24. [The safety of blood and blood products].
    Löwer J
    Internist (Berl); 1994 Oct; 35(10):929-33. PubMed ID: 8002228
    [No Abstract]   [Full Text] [Related]  

  • 25. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
    Malm K; von Sydow M; Andersson S
    Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS.
    Zhang W; Hu D; Xi Y; Zhang M; Duan G
    Int J Infect Dis; 2006 Nov; 10(6):475-80. PubMed ID: 17049292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of pre- and post-transfusion serological screening in France in 2001].
    Daurat G; Fressy P; Duedari N; Le Blanc G; Taverne D; Ounnoughène N; Pillonel J
    Transfus Clin Biol; 2004 Jul; 11(3):153-60. PubMed ID: 15488728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare and Medicaid programs; hospital standard for potentially HIV infectious blood and blood products--HCFA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47423-34. PubMed ID: 10160338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion and HIV.
    Busch MP
    Curr Opin Hematol; 1994 Nov; 1(6):438-42. PubMed ID: 9371320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the risk of HIV transmission through blood transfusion by donor self-deferral.
    Urwijitaroon Y; Barusrux S; Romphruk A; Puapairoj C; Pakote L
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):452-6. PubMed ID: 9185252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
    Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
    East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing the risk of transmission of HIV by blood transfusion.
    Bull World Health Organ; 1990; 68(2):262-4, 268-71. PubMed ID: 2364484
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.
    Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO
    East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of HIV transmission through blood transfusions is decreasing.
    N Y State J Med; 1989 Dec; 89(12):695-6. PubMed ID: 2594269
    [No Abstract]   [Full Text] [Related]  

  • 38. Interim recommendations for deferral of donors at increased risk for HIV-1 Group O infection; guidance document; availability--FDA. Notice.
    Fed Regist; 1997 Sep; 62(184):49695. PubMed ID: 10173802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of HIV transmission by blood transfusion].
    Köhler M
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):46-8. PubMed ID: 7727964
    [No Abstract]   [Full Text] [Related]  

  • 40. Laboratory strategic defense initiatives against transmission of human immune deficiency virus in blood and blood products.
    Ahmed SG
    Niger Postgrad Med J; 2003 Dec; 10(4):254-9. PubMed ID: 15045022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.